Whittier Trust CO Of Nevada Inc Gilead Sciences, Inc. Transaction History
Whittier Trust CO Of Nevada Inc
- $4.02 Billion
- Q4 2024
A detailed history of Whittier Trust CO Of Nevada Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 35,562 shares of GILD stock, worth $3.98 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
35,562
Previous 36,217
1.81%
Holding current value
$3.98 Million
Previous $3.04 Million
8.2%
% of portfolio
0.08%
Previous 0.08%
Shares
31 transactions
Others Institutions Holding GILD
# of Institutions
2,094Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.03 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.76 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.49 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...